Literature DB >> 30043262

Craniopharyngioma adherence: a reappraisal of the evidence.

Ruth Prieto1, José María Pascual2, Verena Hofecker3, Eduard Winter3, Inés Castro-Dufourny4, Rodrigo Carrasco5, Laura Barrios6.   

Abstract

Craniopharyngioma (CP) adherence represents a most baffling problem for the neurosurgeon. The highest priority of current surgical treatment is to maximize tumor removal without compromising the patients' long-term functional outcome. Surgical damage to the hypothalamus may be avoided or at least ameliorated with a precise knowledge regarding the type of adherence for each case. This article presents a comprehensive review of the pathological, surgical, and radiological sources of evidence supporting that CP adherence, despite being heterogenous, is characterized by repeating patterns. The key underlying factors of CP adherence are also discussed. Three components define the type of adherence for each case: (i) the intracranial structures attached to the tumor, (ii) the adherence morphology, and (iii) the adhesion strength. Combination of these three components gives rise to five hierarchical levels of increased risk of hypothalamic injury during tumor removal. Tumor topography has been identified as the major predictor of the type of CP adherence. The most extensive and strongest adhesions to the hypothalamus occur in CPs originated in the suprasellar cistern that secondarily invade the third ventricle (secondary intraventricular CPs) and in those originated within the third ventricle floor itself (not-strictly intraventricular CPs). Three findings observed on preoperative conventional MRI scans have proven to be reliable predictors of adherence severity. A position of the hypothalamus around the middle portion of the tumor, an amputated pituitary stalk, and an elliptical tumor shape points to the severe and critical risk levels, and in those cases, a safer limited removal is strongly recommended.

Entities:  

Keywords:  Adherence; Attachment; Craniopharyngioma; Gliosis; Hypothalamic injury; Infundibulum

Year:  2018        PMID: 30043262     DOI: 10.1007/s10143-018-1010-9

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  97 in total

1.  Intraventricular craniopharyngioma: morphological analysis and outcome evaluation of 17 cases.

Authors:  Jun Pan; Songtao Qi; Yuntao Lu; Jun Fan; Xi'an Zhang; Jie Zhou; Junxiang Peng
Journal:  Acta Neurochir (Wien)       Date:  2011-01-27       Impact factor: 2.216

2.  Pathological and clinical basis of the indications for treatment of craniopharyngiomas.

Authors:  T Kobayashi; N Kageyama; J Yoshida; N Shibuya; T Yonezawa
Journal:  Neurol Med Chir (Tokyo)       Date:  1981-01       Impact factor: 1.742

3.  "Moustache" appearance in craniopharyngiomas: unique magnetic resonance imaging and computed tomographic findings of perifocal edema.

Authors:  S Higashi; J Yamashita; H Fujisawa; Y Yamamoto; M Kadoya
Journal:  Neurosurgery       Date:  1990-12       Impact factor: 4.654

4.  Jakob Erdheim (1874-1937): father of hypophyseal-duct tumors (craniopharyngiomas).

Authors:  José M Pascual; María Rosdolsky; Ruth Prieto; Sewan Strauβ; Eduard Winter; Walter Ulrich
Journal:  Virchows Arch       Date:  2015-06-19       Impact factor: 4.064

5.  Correlation of clinical and pathological features in surgically treated craniopharyngiomas.

Authors:  T E Adamson; O D Wiestler; P Kleihues; M G Yaşargil
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

6.  Intraventricular craniopharyngiomas: surgical management and outcome analyses in 24 cases.

Authors:  Tao Yu; Xingwen Sun; Xiaohui Ren; Xiangli Cui; Junmei Wang; Song Lin
Journal:  World Neurosurg       Date:  2014-06-14       Impact factor: 2.104

Review 7.  Ectopic recurrence of craniopharyngioma along the surgical route: case report and literature review.

Authors:  Rossana Romani; Mika Niemelä; Ozgür Celik; Puchong Isarakul; Anders Paetau; Juha Hernesniemi
Journal:  Acta Neurochir (Wien)       Date:  2009-06-05       Impact factor: 2.216

Review 8.  Pathology of craniopharyngiomas: clinical import of pathological findings.

Authors:  D C Miller
Journal:  Pediatr Neurosurg       Date:  1994       Impact factor: 1.162

Review 9.  Multiple intracranial seeding of craniopharyngioma after repeated surgery--case report.

Authors:  Hiroaki Nomura; Masanori Kurimoto; Shoichi Nagai; Nakamasa Hayashi; Yutaka Hirashima; Eiji Tsukamoto; Shunro Endo
Journal:  Neurol Med Chir (Tokyo)       Date:  2002-06       Impact factor: 1.742

10.  Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children.

Authors:  Robert E Elliott; Kevin Hsieh; Tsivia Hochm; Ilana Belitskaya-Levy; Jessica Wisoff; Jeffrey H Wisoff
Journal:  J Neurosurg Pediatr       Date:  2010-01       Impact factor: 2.375

View more
  7 in total

1.  Understanding treatment options in craniopharyngioma better.

Authors:  Songtao Qi
Journal:  Nat Rev Dis Primers       Date:  2020-04-16       Impact factor: 52.329

Review 2.  Hypothalamic syndrome.

Authors:  Hermann L Müller; Maithé Tauber; Elizabeth A Lawson; Jale Özyurt; Brigitte Bison; Juan-Pedro Martinez-Barbera; Stephanie Puget; Thomas E Merchant; Hanneke M van Santen
Journal:  Nat Rev Dis Primers       Date:  2022-04-21       Impact factor: 52.329

Review 3.  Update on management of craniopharyngiomas.

Authors:  Fraser Henderson; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2021-11-22       Impact factor: 4.130

4.  Reinvestigating Tumor-Ventricle Relationship of Craniopharyngiomas With Predominantly Ventricular Involvement: An Endoscopic Endonasal Series Based on Histopathological Assessment.

Authors:  Jun Fan; Yi Liu; Chaohu Wang; Zhanpeng Feng; Jun Pan; Yuping Peng; Junxiang Peng; Yun Bao; Jing Nie; Binghui Qiu; Songtao Qi
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

5.  Status Quo and Research Trends of Craniopharyngioma Research: A 10-Year Bibliometric Analyses (From 2011 to 2020).

Authors:  Tianhua Li; Anming Yang; Guangjie Liu; Shisheng Zou; Yiguang Chen; Bowen Ni; Yi Liu; Jun Fan
Journal:  Front Oncol       Date:  2021-09-30       Impact factor: 6.244

6.  Craniopharyngioma and the Third Ventricle: This Inescapable Topographical Relationship.

Authors:  José María Pascual; Ruth Prieto
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

Review 7.  Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm.

Authors:  Francesco Calvanese; Timothée Jacquesson; Romain Manet; Alexandre Vasiljevic; Hélène Lasolle; Francois Ducray; Gerald Raverot; Emmanuel Jouanneau
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.